Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria

HIV Medicine

Volumn 13, Issue 9, 2012, Pages 526-532

  Samarawickrama, A ^a,b   Cai, M ^c   Smith, E R ^b,c   Nambiar, K ^a,b   Sabin, C ^d   Fisher, M ^b   Gilleece, Y ^b   Holt, S G ^b,c  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b Worthing Hospital   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Albuminuria; HIV infection; Proteinuria; Urine albumin creatinine ratio; Urine protein creatinine ratio

Indexed keywords

ALBUMIN; ANTIRETROVIRUS AGENT; CREATININE; PHOSPHATE; PROTEIN; PROTEINASE INHIBITOR; TENOFOVIR;

ADULT; ARTICLE; CREATININE URINE LEVEL; DRUG USE; FEMALE; GLOMERULAR DYSFUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PATIENT ASSESSMENT; PATIENT CODING; PHOSPHATE EXCRETION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RETROSPECTIVE STUDY; TUBULAR DYSFUNCTION; URINE ALBUMIN CREATINIE RATIO; URINE ALBUMIN TOTAL PROTEIN RATIO; URINE PROTEIN CREATININE RATIO;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALBUMINURIA; BIOLOGICAL MARKERS; CREATININE; DECISION MAKING; ENGLAND; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEINURIA; RETROSPECTIVE STUDIES;

EID: 84866156096     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2012.01003.x     Document Type: Article

References (26)

1. Post FA, Holt SG. Recent developments in HIV and the kidney. Curr Opin Infect Dis 2009; 22: 43-48.
2. Szczech LA, Gupta SK, Habash R etal. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66: 1145-1152.
3. de Silva TI, Post FA, Griffin MD, Dockerell DH. HIV-1 infection and the kidney: an evolving challenge in HIV medicine. Mayo Clin Proc 2007; 82: 1103-1116.
4. Berliner AR, Fine DM, Lucas GM etal. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 2008; 28: 478-486.
5. Wyatt CM, Morgello S, Katz-Malamed R etal. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int 2009; 75: 428-434.
6. Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med 2009; 10: 329-336.
7. Gazzard BG, Anderson J, Babiker A etal. BHIVA Treatment Guidelines Writing Group. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 2008; 9: 563-608.
8. Gallant JE, Staszewski S, Pozniak AL etal. 903 Study Group. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naïve patients: a 3-year randomized trial. JAMA 2004; 292: 191-201.
9. Pozniak AL, Gallant JE, DeJesus E etal. Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes-a 96-week analysis. J Acquir Immune Defic Syndr 2006; 43: 535-540.
10. Mocroft A, Kirk O, Gatell J etal. Chronic renal failure among HIV-1-infected patients. AIDS 2007; 21: 1119-1127.
11. Nelson MR, Katlama C, Montaner JS etal. The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. AIDS 2007; 21: 1273-1281.
12. Peyriere H, Reynes J, Rouanet I etal. Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr 2004; 35: 269-273.
13. Woodward CL, Hall AM, Williams IG etal. Tenofovir-associated renal and bone toxicity. HIV Med 2009; 10: 482-487.
14. Gupta SK. Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system. AIDS Patient Care STDS 2008; 22: 99-103.
15. Dauchy FA, Lawson-Ayayi S, de la Faille R etal. Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy. Kidney Int 2011; 80: 302-309.
16. Fux CA, Simcock M, Wolbers M etal.; Swiss HIV Cohort Study. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antivir Ther 2007; 12: 1165-1173.
17. Goicoechea M, Liu S, Best B etal.; California Collaborative Treatment Group 578 Team. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. J Infect Dis 2008; 197: 102-108.
18. Gallant JE, Moore RD. Renal function with use of a tenofovir-containing initial antiretroviral regimen. AIDS 2009; 23: 1971-1975.
19. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem 2009; 46: 205-217.
20. Peterson PA, Evrin PE, Berggard I. Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein. J Clin Invest 1969; 48: 1189-1198.
21. Nielsen R, Christensen EI. Proteinuria and events beyond the slit. Pediatr Nephrol 2010; 25: 813-822.
22. Smith ER, Ca MMX, McMahon LP, Wright DA, Holt SG. The value of simultaneous measurement of urinary albumin and total protein in proteinuric patients. Nephrol Dial Transplant 2011 [Epub ahead of print].
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
24. Mocroft A, Kirk O, Reiss P etal. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 2010; 24: 1667-1678.
25. Levey AS, Coresh J, Balk E etal. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
26. Jung O, Bickel M, Ditting T etal. Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity. Nephrol Dial Transplant 2004; 9: 2250-2258.